Live at SynBioBeta
Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that...
top of page
Search
Antheia
- May 12
Leveraging Synthetic Biology for Resilient Pharma Supply Chains and Accessible Medicines
Antheia's Associate Member Spotlight was originally published on the Association for Accessible Medicines blog, which can be found here...
Antheia
- Apr 26
Advancing the U.S. Bioeconomy and Building Resilient Pharmaceutical Supply Chains
We continue to see the U.S. government setting policy priorities that underscore the importance of both building a robust American...
Antheia
- Apr 25
Synthetic Chemistry in Pharma
This blog is part of an educational series about synthetic chemistry. If you missed our introductory primer, you can find it here. In...
Antheia
- Apr 6
Antheia Appoints John Nicols to Chair its Board of Directors
Brings 30+ years of experience leading biotechnology and specialty chemical companies Menlo Park, CA – April 6, 2023 – Antheia, the...
Antheia
- Mar 28
In the News: Forbes' Top Ten Women Founders in the Synthetic Biology Industry
Our co-founder and CEO, Christina Smolke, was named to Forbes’ list of top ten women founders taking the synthetic biology world by...
Antheia
- Mar 2
Introducing Jesse Ahrendt, Antheia’s SVP of Quality Assurance & Regulatory Affairs
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our...
Antheia
- Feb 16
Synthetic Biology vs Synthetic Chemistry: A Primer
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active...
Antheia
- Dec 8, 2022
Antheia's 2022 in Review: A Year of Value
Dear colleagues, friends, and followers: This year has been ripe with growth, major achievements, and opportunities to showcase who and...
Antheia
- Dec 7, 2022
In the News: Drug Discovery and Development 2023 Predictions
Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take...
Antheia
- Nov 20, 2022
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency...
Antheia
- Oct 30, 2022
In the News: Contract Pharma, Leveraging Fermentation to Produce Complex APIs
In this Contract Pharma Q&A, we sat down with Kristin Brooks to discuss how our company uses fermentation to produce complex APIs for...
![Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]](https://static.wixstatic.com/media/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png/v1/fill/w_439,h_330,fp_0.50_0.50,q_95,enc_auto/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png)
Antheia
- Sep 28, 2022
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Antheia CEO and co-founder Christina Smolke shared how synthetic biology can help solve pressing pharma challenges during the 2022 CPHI...
Antheia
- Aug 25, 2022
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Dive into DSP in the final edition of our Demystifying SynBio series. If you’re just joining us, be sure to catch up on parts I, II, III,...
Antheia
- Aug 16, 2022
Introducing Guerin Kob, Antheia’s VP of Supply Chain
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply...
Antheia
- Jul 18, 2022
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Learn more about synbio and the tools and technologies advancing this field in Part I, Part II, and Part III of this blog series....
Antheia
- Jun 22, 2022
Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
Financing will support new plant at Antheia headquarters to accelerate scale up for company’s pipeline of plant-based compounds; plant...
Antheia
- Jun 12, 2022
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Just joining us? Check out Part I and Part II of the series. Synthetic biology is often touted as a software-driven and...
Antheia
- Jun 6, 2022
Introducing CPO Heidi Pucel
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people...
Antheia
- Apr 14, 2022
In the News: Antheia Senior Scientist Involved in Cancer Research Discovery
Senior Scientist Chunshun Li received accolades for his contribution to a recent University of Hawaii Cancer Center discovery. In support...
Antheia Newsroom
bottom of page